These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 17276368)

  • 1. HHV-6 and the immune system: mechanisms of immunomodulation and viral escape.
    Lusso P
    J Clin Virol; 2006 Dec; 37 Suppl 1():S4-10. PubMed ID: 17276368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential HHV-6A gene expression in T cells and primary human astrocytes based on multi-virus array analysis.
    Yao K; Mandel M; Akyani N; Maynard K; Sengamalay N; Fotheringham J; Ghedin E; Kashanchi F; Jacobson S
    Glia; 2006 Jun; 53(8):789-98. PubMed ID: 16541415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral interactions in human lymphoid tissue: Human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CD4 modulation.
    Lisco A; Grivel JC; Biancotto A; Vanpouille C; Origgi F; Malnati MS; Schols D; Lusso P; Margolis LB
    J Virol; 2007 Jan; 81(2):708-17. PubMed ID: 17065205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific CD8⁺ T cells recognize human herpesvirus 6B.
    Martin LK; Schub A; Dillinger S; Moosmann A
    Eur J Immunol; 2012 Nov; 42(11):2901-12. PubMed ID: 22886850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic effects of human herpesvirus 6 in human lymphoid tissue ex vivo.
    Grivel JC; Santoro F; Chen S; Fagá G; Malnati MS; Ito Y; Margolis L; Lusso P
    J Virol; 2003 Aug; 77(15):8280-9. PubMed ID: 12857897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct effects of human herpesvirus 6 and human herpesvirus 7 on surface molecule expression and function of CD4+ T cells.
    Furukawa M; Yasukawa M; Yakushijin Y; Fujita S
    J Immunol; 1994 Jun; 152(12):5768-75. PubMed ID: 7911490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of dendritic cells infected with human herpesvirus 6 in virus transmission to CD4(+) T cells.
    Takemoto M; Imasawa T; Yamanishi K; Mori Y
    Virology; 2009 Mar; 385(2):294-302. PubMed ID: 19144370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of MAPK in CD4(+) T cells toll-like receptor 9-mediated signaling following HHV-6 infection.
    Chi J; Wang F; Li L; Feng D; Qin J; Xie F; Zhou F; Chen Y; Wang J; Yao K
    Virology; 2012 Jan; 422(1):92-8. PubMed ID: 22055432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating immunoregulatory gene networks in human herpesvirus type 6-infected T cells.
    Takaku T; Ohyashiki JH; Zhang Y; Ohyashiki K
    Biochem Biophys Res Commun; 2005 Oct; 336(2):469-77. PubMed ID: 16140273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral replication-independent blockade of dendritic cell maturation and interleukin-12 production by human herpesvirus 6.
    Smith AP; Paolucci C; Di Lullo G; Burastero SE; Santoro F; Lusso P
    J Virol; 2005 Mar; 79(5):2807-13. PubMed ID: 15708999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulation and immunosuppression by human herpesvirus 6A and 6B.
    Dagna L; Pritchett JC; Lusso P
    Future Virol; 2013 Mar; 8(3):273-287. PubMed ID: 24163703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Human herpesvirus-6 infection induces IL-10 production in monocytes].
    Li C; Goodrich JM; Yang X
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Jun; 12(2):151-4. PubMed ID: 12515195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of human herpesviruses 6 and 7 in patients with chronic fatigue syndrome.
    Chapenko S; Krumina A; Kozireva S; Nora Z; Sultanova A; Viksna L; Murovska M
    J Clin Virol; 2006 Dec; 37 Suppl 1():S47-51. PubMed ID: 17276369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immune response to HHV-6 and HHV-7].
    Yasukawa M
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():415-20. PubMed ID: 16615507
    [No Abstract]   [Full Text] [Related]  

  • 15. Computational simulation of chronic persistent virus infection: factors determining differences in clinical outcome of HHV-6, HIV-1 and HTLV-1 infections including aplastic, hyperplastic and neoplastic responses.
    Krueger GR; Brandt ME; Wang G; Buja LM
    Anticancer Res; 2004; 24(1):187-97. PubMed ID: 15015596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of cytokine and chemokine responses in patients with primary human herpesvirus 6 infection.
    Yoshikawa T; Kato Y; Ihira M; Nishimura N; Ozaki T; Kumagai T; Asano Y
    J Clin Virol; 2011 Jan; 50(1):65-8. PubMed ID: 21035385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human herpesvirus 6A decreases the susceptibility of macrophages to R5 variants of human immunodeficiency virus 1: possible role of RANTES and IL-8.
    Csoma E; Deli T; Kónya J; Csernoch L; Beck Z; Gergely L
    Virus Res; 2006 Nov; 121(2):161-8. PubMed ID: 16815583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.
    Fausther-Bovendo H; Wauquier N; Cherfils-Vicini J; Cremer I; Debré P; Vieillard V
    AIDS; 2008 Jan; 22(2):217-26. PubMed ID: 18097224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of infection with human herpesvirus-6 in EBV-negative infectious mononucleosis: data acquisition for computer modeling.
    Krueger GR; Bertram G; Ramon A; Koch B; Ablashi DV; Brandt ME; Wang G; Buja LM
    In Vivo; 2001; 15(5):373-80. PubMed ID: 11695232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highlights from 5th International Conference on HHV-6 and -7.
    Komaroff AL; Jacobson S; Ablashi DV; Yamanishi K
    Herpes; 2006 Nov; 13(3):81-2. PubMed ID: 17147913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.